In the case of MMP9, it would have been overlooked as a key player in NRASG12D mutant-driven AML progression if using DESeq2, whereas DEAPR highlighted its role by placing it in the top 10 genes. The gene discussed is MMP9; the disease is acute myeloid leukemia.